Device Gloves

Biogel Pi Pro-Fit

Payments companies reported to CMS as associated with Biogel Pi Pro-Fit. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$11Kassociated payments (2023-2025)
30clinicians with associated payments
1company reporting

By year

2023 $9,925
2024 $447
2025 $385

Payments reported as associated with Biogel Pi Pro-Fit, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Thoracic Surgery (Cardiothoracic Vascular Surgery) $8,813
Adult Reconstructive Orthopaedic Surgery $1,170
Nurse Anesthetist, Certified Registered $228
Anesthesiology $131
Clinical Nurse Specialist $120
Adult Health (Nurse Practitioner) $61.24

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Biogel Pi Pro-Fit

These are the largest totals companies reported as associated with Biogel Pi Pro-Fit. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
David Jayakar Longview, TX Thoracic Surgery (Cardiothoracic Vascular Surgery) $8,812.50
Kim Stearns Cleveland, OH Adult Reconstructive Orthopaedic Surgery $1,169.99
Alisa Jaganjac New York, NY Clinical Nurse Specialist $119.99
Teresa Washington Beachwood, OH Adult Health (Nurse Practitioner) $61.24
William Eddy Fort Worth, TX Nurse Anesthetist, Certified Registered $31.31
Christopher Wang Auburn, NY Sports Medicine (Orthopaedic Surgery) $30.98
Andrea Soares Sacramento, CA Cardiovascular Disease $29.97
Manoj Kesarwani Sacramento, CA Interventional Cardiology $29.96
Benjamin Stripe Sacramento, CA Cardiovascular Disease $29.96
Christina Valle Smith San Ramon, CA Nurse Anesthetist, Certified Registered $23.45

Prescribed Biogel Pi Pro-Fit?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.